Artículos por temáticas

Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials

Tian Hui Kwan A, Arfaie S, Therriault J, Rosa-Neto P, Gauthier S.

Dement Geriatr Cogn Disord. 2020;49(4):334-348. doi: 10.1159/000511506. Epub 2020 Dec 15.

Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease

Turab Naqvi AA, Hasan GM, Hassan MI.

Curr Top Med Chem. 2020;20(12):1059-1073. doi: 10.2174/1568026620666200106125910.

Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov

Takeshima N, Ishiwata K, Sozu T, Furukawa TA.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):97-100. doi: 10.1097/WAD.0000000000000297.

Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies

Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):158-164. doi: 10.14283/jpad.2020.19.

Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis

Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song BJ, Zhou S, Wang X.

Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316.

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Komorowska J, Wątroba M, Szukiewicz D.

Adv Med Sci. 2020 Sep;65(2):415-423. doi: 10.1016/j.advms.2020.08.002. Epub 2020 Aug 29.

The seed of Litchi chinensis fraction ameliorates hippocampal neuronal injury in an Aβ(25-35)-induced Alzheimer's disease rat model via the AKT/GSK-3β pathway

Sun Y, Wu A, Li X, Qin D, Jin B, Liu J, Tang Y, Wu J, Yu C.

Pharm Biol. 2020 Dec;58(1):35-43. doi: 10.1080/13880209.2019.1697298.

Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?

Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I.

Curr Protein Pept Sci. 2020;21(12):1184-1192. doi: 10.2174/1389203721666200226101930.

Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review

Wang Z, Yang Y, Liu M, Wei Y, Liu J, Pei H, Li H.

Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545.

Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents

Gupta SP, Patil VM.

Curr Top Med Chem. 2020;20(13):1195-1213. doi: 10.2174/1568026620666200416091623.

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools

Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11.

The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse

Sohn JH, Lee SH, Kwon YS, Kim JH, Kim Y, Lee JJ.

Medicine (Baltimore). 2020 May 29;99(22):e20240. doi: 10.1097/MD.0000000000020240.

Alzheimer disease triggered by reversible posterior leukoencephalopathy syndrome

Ros Forteza FJ.

Neurologia (Engl Ed). 2020 May;35(4):279-282. doi: 10.1016/j.nrl.2018.01.006. Epub 2018 Mar 8.

Lemborexant: First Approval

Scott LJ.

Drugs. 2020 Mar;80(4):425-432. doi: 10.1007/s40265-020-01276-1.

Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues

Candasamy M, Mohamed Elhassan SA, Kumar Bhattamisra S, Hua WY, Sern LM, Binti Busthamin NA, Mohamad Ilni NB, Shun NS, Baohong L, Ya NS, Ying NW.

Panminerva Med. 2020 Sep;62(3):155-163. doi: 10.23736/S0031-0808.20.03879-3. Epub 2020 Mar 23.